In pancreatic cancer, ST3GAL1 enhances metastatic potential [108] and promotes the synthesis of ligands for Siglec-7 and Siglec-9 on tumour cells to drive tumour-associated macrophage differentiation [109]. Here, ST3GAL1 is linked to neoplasm.